Skip to content

A clinical study of the effect of anti coagulation and defoaming agents in improving the visibility of endoscopy examination

A clinical study of the effect of anti coagulation and defoaming agents in improving the visibility of endoscopy examination

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093573
Enrollment
Unknown
Registered
2024-12-09
Start date
2024-12-09
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Control group:Simethicone
Experimental group A:Simethicone, Streptomycin, Sodium bicarbonate
Experimental group B:Simethicone, acetylcysteine, sodium bicarbonate

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 80 years old; 2. Those who meet the routine indications for gastrointestinal endoscopy and have no serious contraindications.

Exclusion criteria

Exclusion criteria: 1. Patients with heart, liver and kidney insufficiency; 2. Pregnant and lactating patients; 3. Patients with blood electrolyte disorders and ascites; 4. Patients with severe asthma; 5. Those who are allergic to the drug in this study; 6. Patients with pyloric obstruction, severe gastric ulcer perforation, food retention and related gastroscopy that are not suitable for gastroscopy; 7. Those with a history of gastric or esophageal surgery; 8. People with coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
Mucosal clarity;

Secondary

MeasureTime frame
Disease detection rate;Incidence rate of adverse events;

Countries

China

Contacts

Public ContactKun Chen

Beijing Friendship Hospital, Capital Medical University

13011193716@126.com+86 130 1119 3716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026